The Food and Drug Administration cleared the way Monday for expanded testing of the drug THA, a promising drug to treat Alzheimer's Disease. Arcadia resident Dr. William Summers first reported that THA was beneficial to Alzheimer's patients in 1986 in an article in the New England Journal of Medicine.